Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

被引：99

作者：

James, C

Delhommeau, F

Marzac, C

Teyssandier, I

Le Couédic, JP

Giraudier, S

Roy, L

Saulnier, P

Lacroix, L

Maury, S

Tulliez, M

Vainchenker, W

Ugo, V

Casadevall, N

机构：

[1] Hop Hotel Dieu, Hematol Lab, F-75004 Paris, France

[2] Univ Paris 11, Inst Gustave Roussy, INSERM, U362, Villejuif, France

[3] Hematol Lab, Creteil, France

[4] CHU Poitiers, Serv Oncohematol, Poitiers, France

[5] Inst Gustave Roussy, Translat Lab, Villejuif, France

[6] CHU Brest, Hematol Lab, F-29285 Brest, France

来源：

LEUKEMIA | 2006年 / 20卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2404069

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：350 / 353

页数：4

共 8 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[3] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J].

Jones, AV ;

Kreil, S ;

Zoi, K ;

Waghorn, K ;

Curtis, C ;

Zhang, LY ;

Score, J ;

Seear, R ;

Chase, AJ ;

Grand, FH ;

White, H ;

Zoi, C ;

Loukopoulos, D ;

Terpos, E ;

Vervessou, EC ;

Schultheis, B ;

Emig, M ;

Ernst, T ;

Lengfelder, E ;

Hehlmann, R ;

Hochhaus, A ;

Oscier, D ;

Silver, RT ;

Reiter, A ;

Cross, NCP .

BLOOD, 2005, 106 (06) :2162-2168

[4] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].

Kralovics, R ;

Passamonti, F ;

Buser, AS ;

Teo, S ;

Tiedt, R ;

Passweg, JR ;

Tichelli, A ;

Cazzola, M ;

Skoda, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790

[5] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

[6]

Pearson TC, 1996, LEUKEMIA LYMPHOMA, V22, P87

[7]

Pearson Thomas C., 2000, Hematology Am Soc Hematol Educ Program, P51

[8]

PIERRE R, 2001, WHO CLASSIFICATION T, P32

← 1 →